Investigating how delta-9-tetrahydrocannabinol affects cell structures in HIV infection.
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.
This study is looking at how a compound found in cannabis, THC, might help reduce inflammation and improve symptoms in people with HIV by affecting certain cell structures during the infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York Medical College NIH-funded |
| Lab location | 1 site (Valhalla, United States) |
| Project ID | NIH-10890889 on NIH RePORTER |
What this research studies
This research explores the role of membraneless condensates in cells and how they are influenced by delta-9-tetrahydrocannabinol (THC) during HIV infection. By examining the physicochemical properties of these structures, the study aims to understand their impact on viral replication and inflammation. Patients may benefit from insights into how THC could potentially alleviate symptoms associated with HIV. The research employs advanced biochemical techniques to analyze the interactions between THC and cellular components.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV who are interested in exploring the effects of THC on their condition.
Not a fit: Patients who are not living with HIV or do not have a related condition may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing HIV infection and its associated symptoms.
How similar studies have performed: Previous research has shown promising results regarding the effects of THC on HIV-related symptoms, suggesting that this approach may yield valuable insights.
Where this research is happening
Valhalla, United States
- New York Medical College — Valhalla, United States (Active)
Researchers
- Principal investigator: Okeoma, Chioma M — New York Medical College
- Study coordinator: Okeoma, Chioma M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.